Dianthus Therapeutics, Inc 10-K for FY2024
Dianthus Therapeutics, Inc. (DNTH)
10-K
2025-03-11
For: 2024-12-31
View Original
Added on
April 10, 2026
About this 10-K
Dianthus Therapeutics, Inc filed this 10-K on March 11, 2025, covering the fiscal year ended December 31, 2024 (FY2024).
Headline figures
Fiscal year ended December 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- $6.24M
- up 120.6% from $2.83M a year earlier
- Net loss
- $84.97M
- compared with a net loss of $43.56M a year earlier
- Diluted EPS
- -$2.55
- compared with -$8.45 a year earlier